Literature DB >> 20438045

Choroidal metastases fundus autofluorescence imaging: correlation to clinical, OCT, and fluorescein angiographic findings.

Sribhargava Natesh1, Kimberly J Chin, Paul T Finger.   

Abstract

BACKGROUND AND
OBJECTIVE: To correlate fundus autofluorescence (FAF) characteristics of metastatic choroidal tumors with optical coherence tomography/scanning laser ophthalmoscope (OCT/SLO). PATIENTS AND METHODS: A retrospective review of 10 choroidal metastases in 9 patients.
RESULTS: All tumors were amelanotic, although 8 exhibited surface pigmentation. FAF imaging revealed hyperautofluorescence in areas of focal pigmentation and subretinal fluid with hypoautofluorescent margins (n = 5) corresponding to OCT evidence of retinal pigment epithelial (RPE) thickening and subretinal fluid. Loss of RPE was FAF imaging hypoautofluorescent. FAF images changed with tumor growth. OCT best revealed elevation of the RPE and retina, RPE thickening and folds, and retinal detachment.
CONCLUSION: FAF imaging best defined surface characteristics and tumor margins. FAF imaging hyperautofluorescence correlated to focal hyperpigmentation, subretinal fluid, and advancing tumor edges. OCT better demonstrated intraretinal findings (atrophy, subretinal fluid, and increased and lost RPE). This study shows that FAF imaging and OCT reveal unique tumor characteristics of choroidal metastasis.

Entities:  

Mesh:

Year:  2010        PMID: 20438045     DOI: 10.3928/15428877-20100426-03

Source DB:  PubMed          Journal:  Ophthalmic Surg Lasers Imaging        ISSN: 1542-8877


  14 in total

1.  The application of ultra-wide-field fundus autofluorescence in early metastatic choroidal tumor screening.

Authors:  Pan-Pan Ye; Jia Xu; Zhi-Tao Su; Xiao-Yun Fang; Ke Yao
Journal:  Int J Ophthalmol       Date:  2019-12-18       Impact factor: 1.779

Review 2.  [Intraocular metastases].

Authors:  D Westerwick; F Driever; C H D Le Guin; K W Schmid; K A Metz
Journal:  Pathologe       Date:  2017-11       Impact factor: 1.011

3.  A pilot study to image the vascular network of small melanocytic choroidal tumors with speckle noise-free 1050-nm swept source optical coherence tomography (OCT choroidal angiography).

Authors:  Peter Maloca; Cyrill Gyger; Pascal W Hasler
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-02-04       Impact factor: 3.117

4.  Ocular metastasis of lung adenocarcinoma with ELM4-ALK translocation: A case report with a review of the literature.

Authors:  Kailun Jiang; Seymour Brownstein; Harmanjatinder S Sekhon; Scott A Laurie; Kay Lam; Steven Gilberg; William Britton
Journal:  Saudi J Ophthalmol       Date:  2013-07

5.  Optical coherence tomography of retinal and choroidal tumors.

Authors:  Emil Anthony T Say; Sanket U Shah; Sandor Ferenczy; Carol L Shields
Journal:  J Ophthalmol       Date:  2011-07-18       Impact factor: 1.909

Review 6.  Ophthalmic Metastasis of Breast Cancer and Ocular Side Effects from Breast Cancer Treatment and Management: Mini Review.

Authors:  Ilias Georgalas; Theodore Paraskevopoulos; Chryssanthi Koutsandrea; Evgenia Kardara; Panagiotis Malamos; Dimitrios Ladas; Dimitris Papaconstantinou
Journal:  Biomed Res Int       Date:  2015-05-11       Impact factor: 3.411

Review 7.  Choroidal metastases: origin, features, and therapy.

Authors:  Sruthi Arepalli; Swathi Kaliki; Carol L Shields
Journal:  Indian J Ophthalmol       Date:  2015-02       Impact factor: 1.848

8.  Choroidal mass secondary to mucinous cystadenocarcinoma of ovary in a young woman: a life-threatening metastasis.

Authors:  Saidatulakma Shariff; Khairy Shamel Sonny Teo; Wan Hazabbah Wan Hitam
Journal:  Rom J Ophthalmol       Date:  2021 Apr-Jun

9.  Choroidal metastasis of adenocarcinoma of the lung presenting as pigmented choroidal tumor.

Authors:  Shahar Frenkel; Jacob Pe'er
Journal:  Case Rep Ophthalmol       Date:  2012-09-28

10.  Optical coherence tomography of retinal and choroidal tumors.

Authors:  Emil Anthony T Say; Sanket U Shah; Sandor Ferenczy; Carol L Shields
Journal:  J Ophthalmol       Date:  2011-06-08       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.